Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

What if a $5 dog dewormer could outsmart cancer's deadly fuel hack—while Big Pharma's $100K chemo flops? Dr. Thomas Seyfried just exposed 2025's oncology earthquake in this explosive 2:23 clip. Cancer pioneer Seyfried—author of Cancer as a Metabolic Disease—reveals why antiparasitics Fenbendazole and Mebendazole (structural twins) crush tumors: They...

JoeTippen's profile picture

Joe Tippens

120,175 subscribers

39,574 Aufrufe • vor 8 Monaten •via X (Twitter)

Gesundheit & WellnessNachrichten & PolitikWissenschaft & Technologie
LIVE

Anya Rossi• Live Now

Private livecam show

0 Kommentare

Keine Kommentare verfügbar

Kommentare vom Original-Post werden hier angezeigt

Ähnliche Videos

🚨Dr. Thomas Seyfried reveals a stunning connection: Parasite drugs fenbendazole & mebendazole kill cancer—both cancer cells & parasites rely on identical energy of glucose & glutamine. These drugs disrupt that pathway exactly the same, starving tumors just like they do worms. This is why we are seeing remarkable outcomes in research with these so-called "dog dewormers." Are you or someone you love ready to consider anti-parasite treatments for cancer, or does it sound too out there? Dr Thomas Seyfried 'Press-Pulse Cancer Therapy Protocol' Is Linked Below...
2:11

🚨Dr. Thomas Seyfried reveals a stunning connection: Parasite drugs fenbendazole & mebendazole kill cancer—both cancer cells & parasites rely on identical energy of glucose & glutamine. These drugs disrupt that pathway exactly the same, starving tumors just like they do worms. This is why we are seeing remarkable outcomes in research with these so-called "dog dewormers." Are you or someone you love ready to consider anti-parasite treatments for cancer, or does it sound too out there? Dr Thomas Seyfried 'Press-Pulse Cancer Therapy Protocol' Is Linked Below...

Valerie Anne Smith

18,350 Aufrufe • vor 7 Monaten

Dr. Thomas Seyfried drops a bombshell: Parasite drugs like fenbendazole & mebendazole crush cancer — because cancer cells & parasites use the exact same energy pathway (glucose + glutamine). The drug doesn't care if it's a worm or a tumor — it starves both. Not saying cancer is a parasite… but the shared metabolism explains why these "dog dewormers" are showing insane results in studies. 2:11 clip — game-changing insight Would you try a parasite med for cancer? Or is this too wild?
2:11

Dr. Thomas Seyfried drops a bombshell: Parasite drugs like fenbendazole & mebendazole crush cancer — because cancer cells & parasites use the exact same energy pathway (glucose + glutamine). The drug doesn't care if it's a worm or a tumor — it starves both. Not saying cancer is a parasite… but the shared metabolism explains why these "dog dewormers" are showing insane results in studies. 2:11 clip — game-changing insight Would you try a parasite med for cancer? Or is this too wild?

Camus

272,275 Aufrufe • vor 7 Monaten

Dr. Thomas Seyfried reveals why parasite drugs like fenbendazole & mebendazole crush cancer cells: They target the exact same energy pathway that cancer cells hijack — fermentation of glucose and glutamine — the same pathway many parasites use once settled in tissue. Short science nugget: Fenbendazole and mebendazole disrupt microtubule formation and block glucose/glutamine uptake, starving cancer cells of their primary fuels while sparing healthy cells that rely more on oxidative phosphorylation (peer-reviewed in vitro & animal studies, e.g., Dogra et al. 2018, Zhang et al. 2021, and Seyfried lab publications) Key points from Seyfried: - Structurally almost identical → likely equally effective - Cancer is not a parasite, but it metabolizes like one - These drugs don’t care — they hit the shared vulnerability Cocktails of them may work even better. Is this the overlooked cancer weapon big pharma ignores? Have you or someone you know explored benzimidazoles like fenbendazole/mebendazole?
2:11

Dr. Thomas Seyfried reveals why parasite drugs like fenbendazole & mebendazole crush cancer cells: They target the exact same energy pathway that cancer cells hijack — fermentation of glucose and glutamine — the same pathway many parasites use once settled in tissue. Short science nugget: Fenbendazole and mebendazole disrupt microtubule formation and block glucose/glutamine uptake, starving cancer cells of their primary fuels while sparing healthy cells that rely more on oxidative phosphorylation (peer-reviewed in vitro & animal studies, e.g., Dogra et al. 2018, Zhang et al. 2021, and Seyfried lab publications) Key points from Seyfried: - Structurally almost identical → likely equally effective - Cancer is not a parasite, but it metabolizes like one - These drugs don’t care — they hit the shared vulnerability Cocktails of them may work even better. Is this the overlooked cancer weapon big pharma ignores? Have you or someone you know explored benzimidazoles like fenbendazole/mebendazole?

Camus

88,248 Aufrufe • vor 5 Monaten

"Why would a parasite drug kill cancer? Because cancer cells act like parasites." Dr. Thomas Seyfried reveals they share a core metabolic pathway: glutaminolysis. Drugs like Mebendazole target this Achilles' heel. This isn't just a new treatment; it's a new paradigm for oncology.
0:25

"Why would a parasite drug kill cancer? Because cancer cells act like parasites." Dr. Thomas Seyfried reveals they share a core metabolic pathway: glutaminolysis. Drugs like Mebendazole target this Achilles' heel. This isn't just a new treatment; it's a new paradigm for oncology.

Camus

119,215 Aufrufe • vor 10 Monaten

Parasite drugs that kill cancer cells? The industry jacks up the price. Dr. Thomas Seyfried says cheap medications like Mebendazole and Fenbendazole target the same metabolic pathways in cancer cells that parasites use to survive. But once they show promise, the price skyrockets. He compared it to Martin Shkreli hiking EpiPen costs. Repurposed drugs like Mebendazole have shown anti-cancer effects in preclinical studies by disrupting microtubule function and glutamine metabolism in tumor cells, but large-scale clinical trials in humans are still limited.
1:17

Parasite drugs that kill cancer cells? The industry jacks up the price. Dr. Thomas Seyfried says cheap medications like Mebendazole and Fenbendazole target the same metabolic pathways in cancer cells that parasites use to survive. But once they show promise, the price skyrockets. He compared it to Martin Shkreli hiking EpiPen costs. Repurposed drugs like Mebendazole have shown anti-cancer effects in preclinical studies by disrupting microtubule function and glutamine metabolism in tumor cells, but large-scale clinical trials in humans are still limited.

Camus

36,269 Aufrufe • vor 1 Monat

Cancer’s fuel is glucose + glutamine. Starve both → tumors choke and die. Thomas Seyfried: “We have not found a single tumor that can survive without glucose and glutamine. Put the body into nutritional ketosis (low sugar, high ketones/fatty acids) and the cancer cells get hammered. Metabolic therapy should be first-line for every patient.” At the end, maybe a small touch of radiation/chemo/immunotherapy to mop up stragglers—but the foundation is metabolic. Tumor cells are metabolically inflexible. Normal cells thrive on ketones; cancer cells cannot. Transition the body’s fuel source → cancer suffocates. If metabolic therapy (ketogenic diet + glutamine targeting) is this powerful, why isn’t it standard protocol? What’s your take—would you push for metabolic therapy first if diagnosed? Or have you seen / tried keto in cancer contexts? Your thoughts 👇
0:59

Cancer’s fuel is glucose + glutamine. Starve both → tumors choke and die. Thomas Seyfried: “We have not found a single tumor that can survive without glucose and glutamine. Put the body into nutritional ketosis (low sugar, high ketones/fatty acids) and the cancer cells get hammered. Metabolic therapy should be first-line for every patient.” At the end, maybe a small touch of radiation/chemo/immunotherapy to mop up stragglers—but the foundation is metabolic. Tumor cells are metabolically inflexible. Normal cells thrive on ketones; cancer cells cannot. Transition the body’s fuel source → cancer suffocates. If metabolic therapy (ketogenic diet + glutamine targeting) is this powerful, why isn’t it standard protocol? What’s your take—would you push for metabolic therapy first if diagnosed? Or have you seen / tried keto in cancer contexts? Your thoughts 👇

Camus

324,926 Aufrufe • vor 4 Monaten

Antiparasitic drugs Mebendazole & Fenbendazole are showing potent activity against cancer. Dr. Thomas Seyfried reveals the reason: cancer cells and parasites share a critical metabolic engine—mitochondrial substrate-level phosphorylation. These drugs target this specific pathway, crippling the energy production that both depend on. This synergy is powerfully enhanced under nutritional ketosis. A new paradigm for a classic drug.
0:34

Antiparasitic drugs Mebendazole & Fenbendazole are showing potent activity against cancer. Dr. Thomas Seyfried reveals the reason: cancer cells and parasites share a critical metabolic engine—mitochondrial substrate-level phosphorylation. These drugs target this specific pathway, crippling the energy production that both depend on. This synergy is powerfully enhanced under nutritional ketosis. A new paradigm for a classic drug.

Camus

310,802 Aufrufe • vor 9 Monaten

🚨World Renowned Cancer Biologist Professor Thomas Seyfried reveals new Ivermectin studies underway for cancer He also presents a new paper on how anti parasitics like Mebendazole and Fenbendazole work Dr. Dominic D’Agostino from University of South Florida mentions he's just received a grant proposal from team DESANTIS, who is investing in Ivermectin and Metabolic Therapies for cancer. D’Agostino - "My Blood Levels of Ivermectin are off the charts" SEYFRIED - "we were planning to do ivermectin studies, but it became such a hot political topic I didn't want to get into it.. but we have a paper in Bio Archives now... it's under review for a bigger journal, on mebendazole the parasite medication" "Knowing that mebendazole targets glycolysis and glutaminolysis pathways... [and] when you put it under calorie restricted ketosis it works really really well" "We haven't tested ivermectin yet but we we have that in the plan" Stunningly, Seyfried mentions how Nutritional Ketosis is the key that unlocks the power of Anti Parasitics.
2:19

🚨World Renowned Cancer Biologist Professor Thomas Seyfried reveals new Ivermectin studies underway for cancer He also presents a new paper on how anti parasitics like Mebendazole and Fenbendazole work Dr. Dominic D’Agostino from University of South Florida mentions he's just received a grant proposal from team DESANTIS, who is investing in Ivermectin and Metabolic Therapies for cancer. D’Agostino - "My Blood Levels of Ivermectin are off the charts" SEYFRIED - "we were planning to do ivermectin studies, but it became such a hot political topic I didn't want to get into it.. but we have a paper in Bio Archives now... it's under review for a bigger journal, on mebendazole the parasite medication" "Knowing that mebendazole targets glycolysis and glutaminolysis pathways... [and] when you put it under calorie restricted ketosis it works really really well" "We haven't tested ivermectin yet but we we have that in the plan" Stunningly, Seyfried mentions how Nutritional Ketosis is the key that unlocks the power of Anti Parasitics.

Humanspective

45,410 Aufrufe • vor 5 Monaten

Cancer has a problem. It needs Glucose and Glutamine to survive. That's where anti parasitic's like Fenbendazole come in. "Cancer can not survive without the sugar Glucose or the amino acid Glutamine, which are the fermentation fuels" “Why would a parasite medication be effective in k*lling cancer? [because] the parasite and the cancer cells, use a common metabolic pathway, the glutaminolysis pathway”. Professor Thomas Seyfried from Boston College thinks that "Cancer cannot be a genetic disease" and mentions that the whole industry has been captured by more toxic treatments. He says what Doctors are learning about cancer is completely wrong. "The medical schools have not yet come to understand this unfortunately [and] many oncologists and physicians have never been trained to know that cancer is a metabolic disease"
3:04

Cancer has a problem. It needs Glucose and Glutamine to survive. That's where anti parasitic's like Fenbendazole come in. "Cancer can not survive without the sugar Glucose or the amino acid Glutamine, which are the fermentation fuels" “Why would a parasite medication be effective in k*lling cancer? [because] the parasite and the cancer cells, use a common metabolic pathway, the glutaminolysis pathway”. Professor Thomas Seyfried from Boston College thinks that "Cancer cannot be a genetic disease" and mentions that the whole industry has been captured by more toxic treatments. He says what Doctors are learning about cancer is completely wrong. "The medical schools have not yet come to understand this unfortunately [and] many oncologists and physicians have never been trained to know that cancer is a metabolic disease"

Humanspective

466,438 Aufrufe • vor 9 Monaten

Cancer is a Metabolic Mitochondrial Disease & can be treated with Ketogenic Nutrition Therapy. Thomas N. Seyfried Dr. Thomas Seyfried PhD The Warburg Effect: Cancer Cells rely almost exclusively on glucose for energy. Dietary change to very low carb intake can effectively “starve” cancer cells. Cited Research:
1:12

Cancer is a Metabolic Mitochondrial Disease & can be treated with Ketogenic Nutrition Therapy. Thomas N. Seyfried Dr. Thomas Seyfried PhD The Warburg Effect: Cancer Cells rely almost exclusively on glucose for energy. Dietary change to very low carb intake can effectively “starve” cancer cells. Cited Research:

Valerie Anne Smith

71,152 Aufrufe • vor 1 Jahr

Dr. Thomas Seyfried drops a bombshell: "We haven't advanced glioblastoma treatment in 100 years—yet standard radiation/chemo often accelerates patient death by flooding tumors with glucose & glutamine." His team's new open-access protocol (metabolic therapy: keto + glutamine targeting) turns deadly brain cancer manageable—not "cured," but indolent. Proof? Patient Pablo Kelly lived 10 years with glioblastoma (married, had 3 kids) on metabolic therapy alone—no radiation/chemo. Died from surgery complications, not the tumor. "The same strategy works for most cancers—they all ferment glucose & glutamine, can't burn ketones." Standard care? "Doing the same stupid thing... and getting angry when shown better options." Watch this powerful 4:58 clip. Cancer as chronic manageable disease—not death sentence? Game-changer or threat to status quo? Your take below.
4:58

Dr. Thomas Seyfried drops a bombshell: "We haven't advanced glioblastoma treatment in 100 years—yet standard radiation/chemo often accelerates patient death by flooding tumors with glucose & glutamine." His team's new open-access protocol (metabolic therapy: keto + glutamine targeting) turns deadly brain cancer manageable—not "cured," but indolent. Proof? Patient Pablo Kelly lived 10 years with glioblastoma (married, had 3 kids) on metabolic therapy alone—no radiation/chemo. Died from surgery complications, not the tumor. "The same strategy works for most cancers—they all ferment glucose & glutamine, can't burn ketones." Standard care? "Doing the same stupid thing... and getting angry when shown better options." Watch this powerful 4:58 clip. Cancer as chronic manageable disease—not death sentence? Game-changer or threat to status quo? Your take below.

Camus

62,484 Aufrufe • vor 7 Monaten

Dr. Thomas Seyfried, a leading cancer researcher and speaker, with Christos Shernopoulos from Semmelweis University, has redefined cancer as a mitochondrial metabolic disease, not genetic. His talks reveal that cancer cells ferment glucose and glutamine to survive. Seyfried builds on Otto Warburg’s findings, showing cancer stems from damaged oxidative phosphorylation, triggering fermentation. Environmental factors like hypoxia, carcinogens, viruses, and inflammation disrupt mitochondria, a common mechanism across all cancers. Seyfried’s discussions challenge the genetic theory, exposing its flaws: some tumors lack mutations, driver genes exist in normal tissues without causing cancer, and nuclear transfer experiments show tumor behavior depends on cytoplasm, not the nucleus. He attributes the genetic dogma to confirmation bias. Seyfried notes a tragic consequence: 1,700 daily U.S. cancer deaths stem from treatments based on a flawed genetic model. He advocates metabolic therapy, starving tumors by lowering glucose and glutamine while elevating ketone bodies, which cancer cells cannot use. Seyfried explains the Press-Pulse Therapeutic Strategy, developed with Dominic D’Agostino, George Yu, and Joseph Maroon. His talks detail how this approach presses glucose down through ketosis and pulses glutamine with drugs, offering a non-toxic way to manage cancer, pioneered at Boston College. Seyfried warns that medical schools do not teach cancer as a metabolic disease, leaving oncologists untrained in this approach. He calls for a revenue model to replace toxic treatments with metabolic therapies, urging a paradigm shift to save lives. Through his speaking engagements, Seyfried envisions a future where cancer loses its fear through effective, non-toxic management. He demands physician training and public awareness to adopt metabolic approaches, simplifying a disease overcomplicated by outdated theories.
6:14

Dr. Thomas Seyfried, a leading cancer researcher and speaker, with Christos Shernopoulos from Semmelweis University, has redefined cancer as a mitochondrial metabolic disease, not genetic. His talks reveal that cancer cells ferment glucose and glutamine to survive. Seyfried builds on Otto Warburg’s findings, showing cancer stems from damaged oxidative phosphorylation, triggering fermentation. Environmental factors like hypoxia, carcinogens, viruses, and inflammation disrupt mitochondria, a common mechanism across all cancers. Seyfried’s discussions challenge the genetic theory, exposing its flaws: some tumors lack mutations, driver genes exist in normal tissues without causing cancer, and nuclear transfer experiments show tumor behavior depends on cytoplasm, not the nucleus. He attributes the genetic dogma to confirmation bias. Seyfried notes a tragic consequence: 1,700 daily U.S. cancer deaths stem from treatments based on a flawed genetic model. He advocates metabolic therapy, starving tumors by lowering glucose and glutamine while elevating ketone bodies, which cancer cells cannot use. Seyfried explains the Press-Pulse Therapeutic Strategy, developed with Dominic D’Agostino, George Yu, and Joseph Maroon. His talks detail how this approach presses glucose down through ketosis and pulses glutamine with drugs, offering a non-toxic way to manage cancer, pioneered at Boston College. Seyfried warns that medical schools do not teach cancer as a metabolic disease, leaving oncologists untrained in this approach. He calls for a revenue model to replace toxic treatments with metabolic therapies, urging a paradigm shift to save lives. Through his speaking engagements, Seyfried envisions a future where cancer loses its fear through effective, non-toxic management. He demands physician training and public awareness to adopt metabolic approaches, simplifying a disease overcomplicated by outdated theories.

Camus

74,454 Aufrufe • vor 1 Jahr

New research reveals that parasite medications like mebendazole and fenbendazole—long ignored by Big Pharma—target the glutamine pathway in cancer cells, starving tumors just as they do parasites. These drugs are cheap, effective, and widely available—so what’s the catch? According to Dr. Thomas Seyfried, the real barrier isn’t science, but profit. Pharmaceutical companies have a playbook: take a 50-cent pill, prove it fights cancer, then hike the price to $300. Sound familiar? (Looking at you, Martin Shkreli.) The paradigm is shifting: cancer is a metabolic disease, not genetic. By understanding tumor metabolism and strategically combining drugs like 6-deoxynorleucine with existing therapies, we can outsmart cancer without bankrupting patients. But here’s the kicker: no one’s being trained to think this way. The system is stuck chasing mutations while ignoring the metabolic roots of the disease. The revolution is here—if we dare to embrace it.
2:10

New research reveals that parasite medications like mebendazole and fenbendazole—long ignored by Big Pharma—target the glutamine pathway in cancer cells, starving tumors just as they do parasites. These drugs are cheap, effective, and widely available—so what’s the catch? According to Dr. Thomas Seyfried, the real barrier isn’t science, but profit. Pharmaceutical companies have a playbook: take a 50-cent pill, prove it fights cancer, then hike the price to $300. Sound familiar? (Looking at you, Martin Shkreli.) The paradigm is shifting: cancer is a metabolic disease, not genetic. By understanding tumor metabolism and strategically combining drugs like 6-deoxynorleucine with existing therapies, we can outsmart cancer without bankrupting patients. But here’s the kicker: no one’s being trained to think this way. The system is stuck chasing mutations while ignoring the metabolic roots of the disease. The revolution is here—if we dare to embrace it.

Camus

508,588 Aufrufe • vor 9 Monaten

14/ Hyperbaric Oxygen Therapy (HBOT) Seyfried sees it as a metabolic add-on. When used with keto + glucose restriction, HBOT floods tumors with oxygen. Normal cells benefit from the oxygen boost. Cancer cells can’t handle the oxidative stress, they get stressed & die.
2:25

14/ Hyperbaric Oxygen Therapy (HBOT) Seyfried sees it as a metabolic add-on. When used with keto + glucose restriction, HBOT floods tumors with oxygen. Normal cells benefit from the oxygen boost. Cancer cells can’t handle the oxidative stress, they get stressed & die.

no.mind

524,670 Aufrufe • vor 1 Jahr

Cancer Is Largely Preventable—Here’s the Science-Backed Solution For decades, we’ve been told cancer is a genetic disease—inescapable, unpredictable, a roll of the dice. But what if that’s wrong? Dr. Thomas Seyfried, a leading cancer researcher, reveals a paradigm-shifting truth: Cancer is a metabolic disease, fueled by the very foods and lifestyles we’ve been conditioned to accept. 🔬 The Science Doesn’t Lie: - High blood sugar = Faster tumor growth. - Low blood sugar = Slower tumor growth. - Cancer cells thrive on glucose & glutamine—but they can’t efficiently use ketones. The Solution? Starve the Tumor. Cancer cells have broken mitochondria, forcing them to rely on fermentation (sugar & glutamine) for survival. But healthy cells can thrive on ketones. This is the key. ✅ How to Shift the Battlefield: 1. Water-only fasting – Deprives tumors of fuel. 2. Ketogenic diet – Replaces glucose with ketones, starving cancer while nourishing the body. 3. Exercise & mitochondrial health – Vigorous movement repairs cellular energy systems. 4. Ditch processed carbs – They feed dysfunction at the deepest level. The result? Tumors lose their energy supply, blood vessels shrink, and the body naturally dismantles them. 🔥 This isn’t theory—it’s biochemistry. The war on cancer isn’t about toxic drugs or blind luck. It’s about controlling the metabolic environment. Want to slash your risk? ✔ Fast strategically. ✔ Go low-carb, high-fat. ✔ Move like your life depends on it. Cancer isn’t just “bad genes.” It’s bad metabolism. And that means you have power over it. — Dr. Thomas Seyfried
1:19

Cancer Is Largely Preventable—Here’s the Science-Backed Solution For decades, we’ve been told cancer is a genetic disease—inescapable, unpredictable, a roll of the dice. But what if that’s wrong? Dr. Thomas Seyfried, a leading cancer researcher, reveals a paradigm-shifting truth: Cancer is a metabolic disease, fueled by the very foods and lifestyles we’ve been conditioned to accept. 🔬 The Science Doesn’t Lie: - High blood sugar = Faster tumor growth. - Low blood sugar = Slower tumor growth. - Cancer cells thrive on glucose & glutamine—but they can’t efficiently use ketones. The Solution? Starve the Tumor. Cancer cells have broken mitochondria, forcing them to rely on fermentation (sugar & glutamine) for survival. But healthy cells can thrive on ketones. This is the key. ✅ How to Shift the Battlefield: 1. Water-only fasting – Deprives tumors of fuel. 2. Ketogenic diet – Replaces glucose with ketones, starving cancer while nourishing the body. 3. Exercise & mitochondrial health – Vigorous movement repairs cellular energy systems. 4. Ditch processed carbs – They feed dysfunction at the deepest level. The result? Tumors lose their energy supply, blood vessels shrink, and the body naturally dismantles them. 🔥 This isn’t theory—it’s biochemistry. The war on cancer isn’t about toxic drugs or blind luck. It’s about controlling the metabolic environment. Want to slash your risk? ✔ Fast strategically. ✔ Go low-carb, high-fat. ✔ Move like your life depends on it. Cancer isn’t just “bad genes.” It’s bad metabolism. And that means you have power over it. — Dr. Thomas Seyfried

Camus

290,791 Aufrufe • vor 1 Jahr

The life expectancy following standard of care for brain cancer is the same today as it was in 1926. Once you know that cancer is a disease driven by glucose and glutamine fermentation and that the very treatments you're using increase glucose and glutamine fermentation...
1:58

The life expectancy following standard of care for brain cancer is the same today as it was in 1926. Once you know that cancer is a disease driven by glucose and glutamine fermentation and that the very treatments you're using increase glucose and glutamine fermentation...

Thomas N. Seyfried

255,636 Aufrufe • vor 1 Jahr

"1,700 People In The US Die Everyday From Cancer...That's 70 Every Hour." Dr Thomas Seyfried, PhD "Cancer Is A very Preventable Disorder. It's Within Your Control...It Is Not Genetic, Cancer Is A Metabolic Disease." Toxic Chemotherapy & Radiation Will Never Lower Cancer Rates. "The Problem Is Our Modern Lifestyle & Habits, We're Doing Everything Wrong. We're Inducing Cancer." "Cancer Is A Very Preventable Disorder. It's Within Your Control, Your Lifestyle, Your Habits." "When The Medical Establishment Acknowledges What I Know About This Disorder, What's Causing It & What We're Not Doing To Prevent It Or Treat It...It Will Be Recognized As The Greatest Tragedy In The History Of Medicine." "We Can Prevent It & Treat It With Metabolic Therapy. You Can Take Away The Risk & Fear Of Getting Cancer." Chemotherapy & Radiation have not reduced cancer rates. 1,700 people die everyday from cancer, that's 70 people every hour. Ketogenic Metabolic Cancer Prevention/Treatment: 1: Fasting For Autophagy & Mitochondrial Health 2: Carbohydrate Restriction/Glucose Elimination 3: Remove Inflammatory Toxic Seed Oils 4: Remove Processed Foods 5: Exercise To Induce Ketosis 6: Targeted Protocol For Cancer(Linked Below) Dr Thomas Seyfried Thomas N. Seyfried is a Professor of Biology, Genetics & Biochemistry at Boston College. He has over 150 peer-reviewed publications & the author of "Cancer as a Metabolic Disease: On the Origin, Management & Prevention of Cancer." "All Major Research Centers Believe Cancer Is A Genetic Disease. But That Belief Is In Stark Contrast To The Data. The Evidence Is Massive To Support That Cancer Is A Metabolic Disorder." "Wolves In The Wild Don't Die Of Cancer, Yet Our Pets #1 Killer Is Cancer. Their Food & Lifestyle Is Killing Them Too." "The Greatest Tragedy In The History Of Medicine Is Knowing The Cause Of Cancer & Yet The Medical Establishment Is Not Advising Changing Lifestyle To Prevent It Or As A Treatment." 👇Fasting/Ketogenic/Ivermectin Cancer Protocol👇 👇Dr Seyfried Case Report Curing Canine Cancer👇 👇Ketogenic Diet Lung/Brain Cancer Remission👇 Podcast: DiaryOfaCEO Video: @superfoodmood
1:00

"1,700 People In The US Die Everyday From Cancer...That's 70 Every Hour." Dr Thomas Seyfried, PhD "Cancer Is A very Preventable Disorder. It's Within Your Control...It Is Not Genetic, Cancer Is A Metabolic Disease." Toxic Chemotherapy & Radiation Will Never Lower Cancer Rates. "The Problem Is Our Modern Lifestyle & Habits, We're Doing Everything Wrong. We're Inducing Cancer." "Cancer Is A Very Preventable Disorder. It's Within Your Control, Your Lifestyle, Your Habits." "When The Medical Establishment Acknowledges What I Know About This Disorder, What's Causing It & What We're Not Doing To Prevent It Or Treat It...It Will Be Recognized As The Greatest Tragedy In The History Of Medicine." "We Can Prevent It & Treat It With Metabolic Therapy. You Can Take Away The Risk & Fear Of Getting Cancer." Chemotherapy & Radiation have not reduced cancer rates. 1,700 people die everyday from cancer, that's 70 people every hour. Ketogenic Metabolic Cancer Prevention/Treatment: 1: Fasting For Autophagy & Mitochondrial Health 2: Carbohydrate Restriction/Glucose Elimination 3: Remove Inflammatory Toxic Seed Oils 4: Remove Processed Foods 5: Exercise To Induce Ketosis 6: Targeted Protocol For Cancer(Linked Below) Dr Thomas Seyfried Thomas N. Seyfried is a Professor of Biology, Genetics & Biochemistry at Boston College. He has over 150 peer-reviewed publications & the author of "Cancer as a Metabolic Disease: On the Origin, Management & Prevention of Cancer." "All Major Research Centers Believe Cancer Is A Genetic Disease. But That Belief Is In Stark Contrast To The Data. The Evidence Is Massive To Support That Cancer Is A Metabolic Disorder." "Wolves In The Wild Don't Die Of Cancer, Yet Our Pets #1 Killer Is Cancer. Their Food & Lifestyle Is Killing Them Too." "The Greatest Tragedy In The History Of Medicine Is Knowing The Cause Of Cancer & Yet The Medical Establishment Is Not Advising Changing Lifestyle To Prevent It Or As A Treatment." 👇Fasting/Ketogenic/Ivermectin Cancer Protocol👇 👇Dr Seyfried Case Report Curing Canine Cancer👇 👇Ketogenic Diet Lung/Brain Cancer Remission👇 Podcast: DiaryOfaCEO Video: @superfoodmood

Valerie Anne Smith

198,205 Aufrufe • vor 1 Jahr

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure
3:49

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure

Dr. Zakaria MD

46,717 Aufrufe • vor 1 Monat